Amylyx Pharmaceuticals Ownership 2024 | Who Owns Amylyx Pharmaceuticals Now?
Institutional Ownership
64.30%
Insider Ownership
14.21%
Retail Ownership
21.50%
Institutional Holders
127.00
Amylyx Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 6.23% | 0.00% | 4,223,968 | -1,124,171 | -21.02% | 8,025,539 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 4.92% | 0.01% | 3,340,943 | 3,224,454 | 2768.03% | 6,347,793 | Jun 30, 2024 |
| BLACKROCK INC. | 3.93% | 0.00% | 2,669,741 | -1,804,981 | -40.34% | 5,072,509 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 3.85% | 0.00% | 2,610,420 | -332,766 | -11.31% | 4,959,798 | Jun 30, 2024 |
| ALMITAS CAPITAL LLC | 2.81% | 1.50% | 1,903,851 | 1,903,851 | 100.00% | 3,617,317 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 2.69% | 0.02% | 1,823,420 | 814,813 | 80.79% | 3,464,498 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.26% | 0.00% | 1,535,178 | -936,277 | -37.88% | 2,916,838 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.21% | 0.22% | 1,501,871 | 1,501,871 | 100.00% | 2,853,555 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.21% | 0.15% | 1,500,000 | - | - | 2,850,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.93% | 0.00% | 1,308,181 | 265,598 | 25.48% | 2,485,544 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.91% | 0.01% | 1,297,838 | -135,027 | -9.42% | 2,465,892 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.79% | 0.01% | 1,211,617 | 1,211,617 | 100.00% | 2,300,000 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 1.70% | 0.01% | 1,150,221 | - | - | 2,185,420 | Jun 30, 2024 |
| MORGAN STANLEY | 1.36% | 0.00% | 924,459 | -1,146,194 | -55.35% | 1,756,473 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.20% | 0.00% | 811,488 | 106,888 | 15.17% | 1,541,827 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.16% | 0.00% | 789,127 | -154,936 | -16.41% | 1,499,342 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.92% | 0.01% | 621,927 | 95,239 | 18.08% | 1,181,661 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.87% | 0.00% | 589,111 | 589,111 | 100.00% | 1,119,311 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.84% | 0.00% | 570,857 | -185,312 | -24.51% | 1,084,628 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.77% | 0.01% | 523,772 | - | - | 995,167 | Jun 30, 2024 |
Amylyx Pharmaceuticals's largest institutional shareholder is VANGUARD GROUP INC, holding 6.23% of the company's total share outstanding, currently valued at $8.03M. The top 10 institutional shareholders own together 33.04% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALMITAS CAPITAL LLC | 2.81% | 1.50% | 1,903,851 | 1,903,851 | 100.00% | 3,617,317 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 0.40% | 0.48% | 269,803 | 269,803 | 100.00% | 512,626 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.21% | 0.22% | 1,501,871 | 1,501,871 | 100.00% | 2,853,555 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.21% | 0.15% | 1,500,000 | - | - | 2,850,000 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.40% | 0.09% | 274,551 | -56,900 | -17.17% | 521,647 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.16% | 0.04% | 107,306 | 68,448 | 176.15% | 203,881 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.16% | 0.04% | 108,862 | 108,862 | 100.00% | 206,838 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.31% | 0.03% | 210,612 | 210,612 | 100.00% | 400,163 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.03% | 82,042 | 82,042 | 100.00% | 155,880 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.44% | 0.03% | 300,000 | - | - | 570,000 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.44% | 0.03% | 299,691 | -7,038 | -2.29% | 569,413 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 2.69% | 0.02% | 1,823,420 | 814,813 | 80.79% | 3,464,498 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.15% | 0.02% | 100,000 | - | - | 190,000 | Jun 30, 2024 |
| STATE OF WYOMING | 0.09% | 0.02% | 61,784 | 61,784 | 100.00% | 117,390 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.47% | 0.01% | 321,867 | -202,760 | -38.65% | 611,547 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.17% | 0.01% | 118,105 | -223,412 | -65.42% | 224,400 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.18% | 0.01% | 118,983 | 6,116 | 5.42% | 226,068 | Jun 30, 2024 |
| LEGACY ADVISORS, LLC | 0.07% | 0.01% | 50,000 | - | - | 95,000 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 1.70% | 0.01% | 1,150,221 | - | - | 2,185,420 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 4.92% | 0.01% | 3,340,943 | 3,224,454 | 2768.03% | 6,347,793 | Jun 30, 2024 |
The largest Amylyx Pharmaceuticals shareholder by % of total assets is ALMITAS CAPITAL LLC. The company owns 1.90M shares of Amylyx Pharmaceuticals (AMLX), representing 1.50% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | 4.92% | 0.01% | 3,340,943 | 3,224,454 | 2768.03% | 6,347,793 | Jun 30, 2024 |
| ALMITAS CAPITAL LLC | 2.81% | 1.50% | 1,903,851 | 1,903,851 | 100.00% | 3,617,317 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.21% | 0.22% | 1,501,871 | 1,501,871 | 100.00% | 2,853,555 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.79% | 0.01% | 1,211,617 | 1,211,617 | 100.00% | 2,300,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 2.69% | 0.02% | 1,823,420 | 814,813 | 80.79% | 3,464,498 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.87% | 0.00% | 589,111 | 589,111 | 100.00% | 1,119,311 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 0.40% | 0.48% | 269,803 | 269,803 | 100.00% | 512,626 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.93% | 0.00% | 1,308,181 | 265,598 | 25.48% | 2,485,544 | Jun 30, 2024 |
| AVIVA PLC | 0.54% | 0.00% | 363,032 | 217,614 | 149.65% | 689,761 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.31% | 0.03% | 210,612 | 210,612 | 100.00% | 400,163 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.70% | 0.00% | 477,524 | 201,568 | 73.04% | 907,296 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.33% | 0.00% | 220,517 | 138,410 | 168.57% | 418,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.01% | 130,000 | 130,000 | 100.00% | 247,000 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.17% | 0.00% | 113,300 | 113,300 | 100.00% | 215,270 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.40% | 0.00% | 272,576 | 113,267 | 71.10% | 517,894 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.16% | 0.04% | 108,862 | 108,862 | 100.00% | 206,838 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.20% | 0.00% | 811,488 | 106,888 | 15.17% | 1,541,827 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.16% | 0.00% | 105,249 | 105,249 | 100.00% | 202,078 | Jun 30, 2024 |
| SAVANT CAPITAL, LLC | 0.14% | 0.00% | 95,878 | 95,878 | 100.00% | 182,169 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.92% | 0.01% | 621,927 | 95,239 | 18.08% | 1,181,661 | Jun 30, 2024 |
As of Jun 30 2024, Amylyx Pharmaceuticals's largest institutional buyer is AQR CAPITAL MANAGEMENT LLC. The company purchased 3.22M stocks of AMLX, valued at $6.35M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 0.23% | - | 154,908 | -1,905,134 | -92.48% | 294,325,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -1,855,886 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 3.93% | 0.00% | 2,669,741 | -1,804,981 | -40.34% | 5,072,509 | Jun 30, 2024 |
| MORGAN STANLEY | 1.36% | 0.00% | 924,459 | -1,146,194 | -55.35% | 1,756,473 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.23% | 0.00% | 4,223,968 | -1,124,171 | -21.02% | 8,025,539 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -1,060,100 | -100.00% | - | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -1,011,412 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.26% | 0.00% | 1,535,178 | -936,277 | -37.88% | 2,916,838 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.08% | - | 55,600 | -914,955 | -94.27% | 106,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.69% | 0.00% | 468,866 | -597,379 | -56.03% | 891,092 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -522,800 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.03% | - | 19,041 | -359,757 | -94.97% | 36,178 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.08% | - | 57,511 | -352,248 | -85.96% | 109,271 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 3.85% | 0.00% | 2,610,420 | -332,766 | -11.31% | 4,959,798 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -324,400 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.09% | 0.00% | 61,720 | -300,150 | -82.94% | 117,268 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -299,452 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.37% | 0.00% | 250,000 | -248,000 | -49.80% | 475,000 | Jun 30, 2024 |
As of Jun 30 2024, Amylyx Pharmaceuticals's biggest institutional seller is STATE STREET CORP. The company sold -1.91M shares of AMLX, valued at $294.32M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALMITAS CAPITAL LLC | 2.81% | 1.50% | 1,903,851 | 1,903,851 | 100.00% | 3,617,317 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.21% | 0.22% | 1,501,871 | 1,501,871 | 100.00% | 2,853,555 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.79% | 0.01% | 1,211,617 | 1,211,617 | 100.00% | 2,300,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.87% | 0.00% | 589,111 | 589,111 | 100.00% | 1,119,311 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 0.40% | 0.48% | 269,803 | 269,803 | 100.00% | 512,626 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.01% | 130,000 | 130,000 | 100.00% | 247,000 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.17% | 0.00% | 113,300 | 113,300 | 100.00% | 215,270 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.16% | 0.04% | 108,862 | 108,862 | 100.00% | 206,838 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.16% | 0.00% | 105,249 | 105,249 | 100.00% | 202,078 | Jun 30, 2024 |
| SAVANT CAPITAL, LLC | 0.14% | 0.00% | 95,878 | 95,878 | 100.00% | 182,169 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.03% | 82,042 | 82,042 | 100.00% | 155,880 | Jun 30, 2024 |
| STATE OF WYOMING | 0.09% | 0.02% | 61,784 | 61,784 | 100.00% | 117,390 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.09% | 0.00% | 57,954 | 57,954 | 100.00% | 110,113 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.05% | 0.00% | 33,365 | 33,365 | 100.00% | 63,394 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 26,032 | 26,032 | 100.00% | 49,461 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.03% | 0.00% | 21,600 | 21,600 | 100.00% | 41,040 | Jun 30, 2024 |
| ZUCKERMAN INVESTMENT GROUP, LLC | 0.03% | 0.00% | 20,000 | 20,000 | 100.00% | 38,000 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.02% | 0.00% | 11,741 | 11,741 | 100.00% | 22,308 | Jun 30, 2024 |
| VIDENT ADVISORY, LLC | 0.02% | 0.00% | 10,843 | 10,843 | 100.00% | 20,603 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 2,528 | 2,528 | 100.00% | 4,803 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 2,193 | 2,193 | 100.00% | 4,167 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | 0.00% | - | 709 | 709 | 100.00% | 2,014 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 380 | Jun 30, 2024 |
Amylyx Pharmaceuticals's largest new institutional shareholder by number of shares is ALMITAS CAPITAL LLC, purchased 1.90M shares, valued at $3.62M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | - | - | - | -1,855,886 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -1,060,100 | -100.00% | - | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -1,011,412 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -522,800 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -324,400 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -299,452 | -100.00% | - | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -240,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -198,029 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -197,300 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -189,796 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -170,000 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -166,896 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -163,900 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -137,973 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | - | - | - | -131,200 | -100.00% | - | Jun 30, 2024 |
| WINTON GROUP LTD | - | - | - | -119,676 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -95,570 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -86,600 | -100.00% | - | Jun 30, 2024 |
| PHOCAS FINANCIAL CORP. | - | - | - | -86,073 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -80,084 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -79,652 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -73,130 | -100.00% | - | Jun 30, 2024 |
| PROFUND ADVISORS LLC | - | - | - | -64,969 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -59,800 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -53,900 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | - | - | - | -53,201 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -51,542 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -44,561 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -38,400 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -33,933 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -33,604 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -32,854 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -31,800 | -100.00% | - | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | - | - | - | -25,849 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -25,031 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -24,349 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -22,500 | -100.00% | - | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | - | -21,376 | -100.00% | - | Jun 30, 2024 |
| PREMIER PATH WEALTH PARTNERS, LLC | - | - | - | -20,265 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -19,700 | -100.00% | - | Jun 30, 2024 |
| ROYAL FUND MANAGEMENT, LLC | - | - | - | -18,600 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -18,141 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -17,357 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -16,500 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -15,600 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -14,717 | -100.00% | - | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | - | - | - | -14,700 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -14,666 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -13,768 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -13,514 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -12,753 | -100.00% | - | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -12,061 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -11,571 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -10,022 | -100.00% | - | Jun 30, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -8,310 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -7,300 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -5,046 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,899 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,726 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -389 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -35 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Amylyx Pharmaceuticals's largest sold out institutional shareholder by shares sold is FRANKLIN RESOURCES INC, sold -1.86M shares, valued at -, as of undefined.
Amylyx Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Voya VARIABLE PRODUCTS TRUST | 1.50% | 537,478 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.24% | 354,468 | - | - | Feb 29, 2024 |
| OBERWEIS FUNDS | 0.17% | 170,000 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.15% | 368,225 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.14% | 6,327 | 6,327 | - | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.10% | 64,781 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.10% | 82,855 | -53,642 | -39.30% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 35,392 | -23,604 | -40.01% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 38,707 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.05% | 446,592 | 222,068 | 98.91% | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.05% | 503,510 | 503,510 | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 260,100 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 113,021 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 194,000 | 5,400 | 2.86% | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.02% | 84,400 | 65,800 | 353.76% | Mar 31, 2024 |
| PRIMECAP Odyssey Funds | 0.02% | 134,600 | -136,900 | -50.42% | Jan 31, 2024 |
| ETFis Series Trust I | 0.02% | 22,130 | 9,907 | 81.05% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 89,639 | -2,804 | -3.03% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,746 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,628,911 | -571,976 | -11.00% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 594,415 | 64,617 | 12.20% | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 28,684 | 465 | 1.65% | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 78,749 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,371 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 12,784 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 100,000 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 189,385 | 24,410 | 14.80% | Jan 31, 2024 |
| ProFunds | 0.00% | 51,657 | 32,751 | 173.23% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 16,863 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 53,676 | 6,085 | 12.79% | Feb 29, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 326,937 | - | - | Jan 31, 2024 |
| UNIFIED SERIES TRUST | 0.00% | 65,000 | 14,000 | 27.45% | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 368,000 | 1,600 | 0.44% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 24,973 | 20,691 | 483.21% | Aug 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 26,993 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 13,684 | 13,684 | - | Mar 31, 2024 |
| NUVEEN INVESTMENT FUNDS INC | 0.00% | 75,752 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 8,584 | 6,931 | 419.30% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 404,437 | -1,798 | -0.44% | Feb 29, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 61,510 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,046 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 14,610 | -25,920 | -63.95% | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 119,947 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,909 | -2,777 | -7.57% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 22,279 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 18,978 | 10,142 | 114.78% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 54,157 | - | - | Feb 29, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 7,817 | 7,817 | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 8,923 | 193 | 2.21% | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 22,352 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,836 | -750 | -8.74% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 148,413 | 37,370 | 33.65% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,842 | -125 | -1.14% | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 13,714 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 32,107 | 32,107 | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 2,500 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 17,357 | -2,818 | -13.97% | Mar 31, 2024 |
| Global X Funds | 0.00% | 22,671 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,382 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 10,702 | 9,694 | 961.71% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 34,848 | 31,575 | 964.71% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 210,896 | 7,307 | 3.59% | Feb 29, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 4,538 | 4,538 | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,267,837 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 760 | -6,213 | -89.10% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 18,000 | 800 | 4.65% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 26,367 | 25,240 | 2239.57% | Feb 29, 2024 |
| LoCorr Investment Trust | 0.00% | 6,241 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 23,482 | 13,443 | 133.91% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 19,391 | -2,315 | -10.67% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 2,225,950 | -127,041 | -5.40% | Mar 31, 2024 |
| Voya PARTNERS INC | 0.00% | 10,800 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 6,701 | 6,701 | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 384,510 | -85,410 | -18.18% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 18,374 | 8,128 | 79.33% | Jan 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 2,396 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 144,163 | 3,475 | 2.47% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 233,713 | 29,607 | 14.51% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 463 | - | - | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 8,134 | 8,134 | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 13,456 | 6,634 | 97.24% | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 507 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,255 | -319 | -12.39% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 19,492 | -78 | -0.40% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 27,430 | 5,196 | 23.37% | Jan 31, 2024 |
| BNY Mellon ETF Trust | 0.00% | 1,432 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 230 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,600 | -200 | -11.11% | Mar 28, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 6,300 | 14,000 | -181.82% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 12,488 | 1,630 | 15.01% | Feb 29, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 9,690 | 9,690 | - | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 5,268 | 5,268 | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 6,664 | 1,407 | 26.76% | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 70,047 | 27,647 | 65.21% | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,040,888 | 633,890 | 155.75% | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 87,018 | - | - | Mar 28, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 30 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 25,689 | -515,290 | -95.25% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 7,615 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,899 | - | - | Feb 29, 2024 |
Amylyx Pharmaceuticals's largest mutual fund holder by % of total assets is "Voya VARIABLE PRODUCTS TRUST", owning 537.48K shares, compromising 1.50% of its total assets.
Amylyx Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 127 | -28.25% |
| 31 Mar, 24 | 177 | -14.08% |
| 31 Dec, 23 | 206 | 8.99% |
| 30 Sep, 23 | 189 | 11.18% |
| 30 Jun, 23 | 170 | 3.66% |
| 31 Mar, 23 | 164 | 10.07% |
| 31 Dec, 22 | 149 | 28.45% |
| 30 Sep, 22 | 116 | 26.09% |
| 30 Jun, 22 | 92 | 19.48% |
| 31 Mar, 22 | 77 | - |
As of 30 Jun 24, 127 institutions are holding Amylyx Pharmaceuticals's shares, representing a decrease of -28.25% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 43,627,452 | -12.05% |
| 31 Mar, 24 | 49,605,091 | -17.71% |
| 31 Dec, 23 | 60,281,733 | 2.30% |
| 30 Sep, 23 | 58,927,724 | 8.03% |
| 30 Jun, 23 | 54,545,075 | 6.17% |
| 31 Mar, 23 | 51,372,953 | 5.75% |
| 31 Dec, 22 | 48,578,630 | 30.36% |
| 30 Sep, 22 | 37,265,816 | 39.98% |
| 30 Jun, 22 | 26,621,999 | 13.67% |
| 31 Mar, 22 | 23,421,051 | - |
Amylyx Pharmaceuticals (AMLX) has 43.63M shares outstanding as of 30 Jun 24, down -12.05% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 64.30% | 1.19% |
| 31 Mar, 24 | 73.58% | 0.92% |
| 31 Dec, 23 | 89.42% | 1.16% |
| 30 Sep, 23 | 87.65% | 1.31% |
| 30 Jun, 23 | 81.76% | 1.38% |
| 31 Mar, 23 | 77.00% | 1.12% |
| 31 Dec, 22 | 83.05% | 2.05% |
| 30 Sep, 22 | 63.67% | 3.05% |
| 30 Jun, 22 | 45.68% | 2.22% |
| 31 Mar, 22 | 45.39% | - |
As of 30 Jun 24, Amylyx Pharmaceuticals is held by 64.30% institutional shareholders, representing a 1.19% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 58 | -33.33% |
| 31 Mar, 24 | 87 | -25.64% |
| 31 Dec, 23 | 117 | 10.38% |
| 30 Sep, 23 | 106 | 11.58% |
| 30 Jun, 23 | 95 | -6.86% |
| 31 Mar, 23 | 102 | 7.37% |
| 31 Dec, 22 | 95 | 26.67% |
| 30 Sep, 22 | 75 | 36.36% |
| 30 Jun, 22 | 55 | -23.61% |
| 31 Mar, 22 | 72 | - |
58 institutional shareholders have increased their position in AMLX stock as of 30 Jun 24 compared to 87 in the previous quarter (a -33.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 47 | -2.08% |
| 31 Mar, 24 | 48 | -4.00% |
| 31 Dec, 23 | 50 | 2.04% |
| 30 Sep, 23 | 49 | 6.52% |
| 30 Jun, 23 | 46 | 21.05% |
| 31 Mar, 23 | 38 | 11.76% |
| 31 Dec, 22 | 34 | 61.90% |
| 30 Sep, 22 | 21 | 50.00% |
| 30 Jun, 22 | 14 | - |
| 31 Mar, 22 | - | - |
47 institutional shareholders have reduced their position in AMLX stock as of 30 Jun 24 compared to 48 in the previous quarter (a -2.08% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 127 | -28.25% | 43,627,452 | -12.05% | 64.30% | 1.19% | 58 | -33.33% | 47 | -2.08% |
| 31 Mar, 24 | 177 | -14.08% | 49,605,091 | -17.71% | 73.58% | 0.92% | 87 | -25.64% | 48 | -4.00% |
| 31 Dec, 23 | 206 | 8.99% | 60,281,733 | 2.30% | 89.42% | 1.16% | 117 | 10.38% | 50 | 2.04% |
| 30 Sep, 23 | 189 | 11.18% | 58,927,724 | 8.03% | 87.65% | 1.31% | 106 | 11.58% | 49 | 6.52% |
| 30 Jun, 23 | 170 | 3.66% | 54,545,075 | 6.17% | 81.76% | 1.38% | 95 | -6.86% | 46 | 21.05% |
| 31 Mar, 23 | 164 | 10.07% | 51,372,953 | 5.75% | 77.00% | 1.12% | 102 | 7.37% | 38 | 11.76% |
| 31 Dec, 22 | 149 | 28.45% | 48,578,630 | 30.36% | 83.05% | 2.05% | 95 | 26.67% | 34 | 61.90% |
| 30 Sep, 22 | 116 | 26.09% | 37,265,816 | 39.98% | 63.67% | 3.05% | 75 | 36.36% | 21 | 50.00% |
| 30 Jun, 22 | 92 | 19.48% | 26,621,999 | 13.67% | 45.68% | 2.22% | 55 | -23.61% | 14 | - |
| 31 Mar, 22 | 77 | - | 23,421,051 | - | 45.39% | - | 72 | - | - | - |
Amylyx Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Amylyx Pharmaceuticals's stock was made by Mazzariello Gina on May 16 2024, selling 10,455 shares at $1.88 per share (valued at $19.65K). The last insider buy of AMLX was made by Quimi Daphne on May 16 2024, buying 2,250 shares at $1.89 per share (worth $4.25K).
Amylyx Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 17 | 1 | 1700.00% |
| Q1 2024 | 9 | 11 | 81.82% |
| Q4 2023 | 6 | 2 | 300.00% |
| Q3 2023 | 2 | 4 | 50.00% |
| Q2 2023 | 9 | 12 | 75.00% |
| Q1 2023 | 32 | 36 | 88.89% |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 6 | 2 | 300.00% |
| Q1 2022 | 36 | 54 | 66.67% |
17 total buy trades, and 1 total sell trades (buy/sell ratio of 17.00%) were made by Amylyx Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | 1 | 200.00% |
| Q1 2024 | - | 9 | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 5 | - |
| Q1 2023 | 1 | 42 | 2.38% |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 7 | - | - |
As of Q2 2024, Insider owners conducted 2 open market buy trades and 1 open market sell trades of Amylyx Pharmaceuticals's stocks.
AMLX Ownership FAQ
Who Owns Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals is owned by institutional shareholders (64.30%), insiders (14.21%), and public (21.50%). The largest institutional shareholder of Amylyx Pharmaceuticals is VANGUARD GROUP INC (6.23% of total shares) and the top mutual fund owner is Voya VARIABLE PRODUCTS TRUST (1.50% of total shares).
Who are the major institutional shareholders of Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals's major institutional shareholders are VANGUARD GROUP INC, AQR CAPITAL MANAGEMENT LLC, BLACKROCK INC., GOLDMAN SACHS GROUP INC, and ALMITAS CAPITAL LLC. The top five shareholders own together 21.74% of the company's share outstanding.
How many Amylyx Pharmaceuticals shareholders are there?
As of Jun 2024, there are 127 institutional shareholders of Amylyx Pharmaceuticals.
What percentage of Amylyx Pharmaceuticals is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 4.22M shares of Amylyx Pharmaceuticals, representing 6.23% of the company's total shares outstanding, valued at $8.03M (as of Jun 2024).
What percentage of Amylyx Pharmaceuticals is owned by AQR CAPITAL MANAGEMENT LLC?
As of Jun 2024, AQR CAPITAL MANAGEMENT LLC holds 3.34M shares of Amylyx Pharmaceuticals (AMLX), compromising 4.92% of the company, valued at $6.35M.
What percentage of Amylyx Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Amylyx Pharmaceuticals. The company owns 2.67M of the company's shares outstanding (worth $5.07M).